| 7081-44-9 |
Cloxacillin Sodium |
Antibiotics |
CAS NO: 7081-44-9
Molecular formula: C19H17ClN3NaO5S.H2O
Molecular weight: 475.88
Standard: EP/BP/USP/IP/CP Application:It has bactericidal effect on resistant staphylococcus aureus |
Appearance: white or almost white powder
Identification:IR,H-NMR PH:5.0~7.0 Water:3.0%~4.5% Assay(HPLC):95.0%~101.0%"
|
| 1173-88-2 |
Oxacillin sodium
|
Antibiotics |
CAS NO: 1173-88-2
Molecular formula: C19H18N3NaO5S
Molecular weight: 423.42
Standard: USP/BP/EP/CP Application:Semi-synthetic antibiotic related to Penicillin. Antibacterial"
|
Appearance: white or almost white powder
Identification:IR,H-NMR PH:4.5~7.5 Water:3.5%~5.0% Assay(HPLC):95.0%~101.0%"
|
| 59798-30-0 |
Mezlocillin sodium
|
Antibiotics |
CAS NO: 59798-30-0
Molecular formula: C21H24N5NaO8S2
Molecular weight: 561.56
Standard: USP/BP/EP/CP Application:Melocillin sodium is a semi - synthetic penicillin drug. It has broad spectrum antibacterial effect on gram-negative and positive bacteria
"
|
Appearance: white or almost white powder
Identification:IR,H-NMR Loss on Drying: ≤0.5% Residue on Ignition:≤0.2% Sulphated Ash:≤0.2% Heavy metals:≤20PPM Assay(HPLC):98%min |
| 54661-82-4 |
Furbenicillin Sodium |
Antibiotics |
CAS NO: 54661-82-4
Molecular formula: C22H22N4O7S.Na
Molecular weight: 509.5
Standard: USP/BP/EP/CP Application: Antibiotics |
Appearance:white or almost white powder
Identification:IR,H-NMR Assay(HPLC):98%min |
| 28002-18-8 |
Sulbenicillin Sodium |
Antibiotics |
CAS NO: 28002-18-8
Molecular formula: C16H16N2Na2O7S2
Molecular weight: 458.41
Standard: USP/BP/EP/CP Application: Antibiotics |
Appearance: white or light-yellow powder
Identification:IR,H-NMR Assay：88.0%~94.0%(C22H24N2O8) PH： 2.0~3.0 Heavy Metals：≤50ppm |
| 220620-09-7 |
Tigecycline |
Antibiotics |
CAS NO: 220620-09-7
Molecular formula: C29H39N5O8
Molecular weight: 585.65
Standard: USP/BP/EP/CP
Application: Antibiotics |
Appearance:Orange crystalline powder
Identification:IR,H-NMR
Solubility:soluble in water ,Dichloromethane , slight soluble in Methanol
Water:≤3.0%
Assay(HPLC):≥98.5%"
|
| 142340-99-6 |
Adefovir dipivoxil |
Anti-virals |
CAS NO: 142340-99-6
Molecular formula: C20H32N5O8P
Molecular weight: 501.48
Standard: USP/BP/EP/CP Application: Antiviral. Treatment of chronic hepatitis B in adults with evidence of active vir |
Appearance: white or almost white powder
Identification:IR,H-NMR Assay(HPLC):≥99% Melting range：129°C~132°C Loss on drying：≤0.5% |
| 202138-50-9 |
Tenofovir disoproxil fumarate |
Anti-virals |
CAS NO: 202138-50-9
Molecular formula: C19H30N5O10P.C4H4O4
Molecular weight: 635.51
Standard: USP/BP/EP/CP Application: Used as an anti-HIV agent. Antiviral.
|
Appearance:white crystalline powder
Identification:IR,H-NMR Assay:95%~103% Fumaric acid:17.5%~19% Loss on drying:≤0.5% Heavy metals :≤10ppm |
| 1190307-88-0 |
Sofosbuvir |
Anti-virals |
CAS NO: 1190307-88-0
Molecular formula: C22H29FN3O9P
Molecular weight: 529.45
Standard: USP/BP/EP/CP Application:Used for the treatment of chronic hepatitis C genotype 1 infection"
|
Appearance:White to off-white powder
Identification:IR,H-NMR Loss on drying:≤0.5% Residue on ignition:≤0.2% Assay:≥99% |
| 209216-23-9 |
Entecavir hydrate |
Anti-virals |
CAS NO: 209216-23-9
Molecular formula: C12H15N5O3.H2O
Molecular weight: 295.30
Standard: USP/BP/EP/CP Application:Used in the treatment of hepatitis B infection |
Appearance:White to off-white crystalline powder
Identification:IR,H-NMR Optical rotation:+24.0°—+28.0° Water:5.8%—6.5% Residue on ignition:≤0.1% Assay:≥99.5% |
| 144060-53-7 |
Febuxostat |
Antigout |
CAS NO: 144060-53-7
Molecular formula: C16H16N2O3S
Molecular weight: 316.37
Standard: USP/BP/EP/CP
Application: Antigout agents |
Appearance:White to off-white crystalline powder
Identification:IR/HPLC
Melting range:205.0℃～209.0℃
Loss on drying:≤0.5%
Residue on ignition:≤0.2%
Heavy metals:≤20ppm
Assay:98.5%~101.0%(on anhydrous substance) |
| 290297-26-6 |
Netupitant |
Anti-nausea |
CAS NO: 290297-26-6
Molecular formula: C30H32F6N4O
Molecular weight: 578.61
Standard: USP/BP/EP/CP
Application: Used to treat nausea and vomiting in patients undergoing cancer chemotherapy |
Appearance:White to off-white crystalline powder
Identification:IR,H-NMR Assay:≥99% |
| 2353-33-5 |
Decitabine |
Anti-Oncology |
CAS NO: 2353-33-5
Molecular formula: C8H12N4O4
Molecular weight: 228.20
Standard: Enterprise standard
Application: Used as cancer treatment, in particular to inhibit the growth of pancreatic endocrine tumor cell lines. Antimetabolites |
Character：White crystalline powder, odorless
Solution：Slight soluble in methanol, sparingly soluble in water and soluble in dimethylaulfoxid (DMSO)
Identification：IR/UV/HPLC
Specific rotation：+73.0~+80.0°
Melting point：192.0~195.0℃
Loss on drying：≤0.5%
Heavy metals：≤10 ppm
Residue on ignition：≤0.1 %
Assay：98.0%~102.0%(Calculated on anhydrous substance) |
| 53123-88-9 |
Rapamycin |
Anti-Oncology |
CAS NO: 53123-88-9
Molecular formula: C51H79NO13
Molecular weight: 914.18
Standard: USP/BP/EP/CP Application: immunosuppressant, antineoplastic |
Appearance:off-white to yellow crystalline powder
Identification:IR,H-NMR Loss on drying:≤0.5% Total impurity:≤2.0% Assay:≥98% |
| 179324-69-7 |
Bortezomib |
Anti-Oncology |
CAS NO: 179324-69-7
Molecular formula: C19H25BN4O4
Molecular weight: 384.24
Standard: Enterprise standard
Application: Molecular targeted Agents |
Appearance:white to off-white crystalline Powder
Identification:H-NRM/LC-MS
Solubility:Very soluble in DMSO or ethanol, about 200mg/ml; insoluble in aqueous solution
Special optical rotation:-41.8~-46.0º
Sulphated ash;≤0.1%
Heavy metals:≤20ppm
Assay(HPLC):99.0%~102.0%(Calculated on anhydrous substance) |
| 877399-52-5 |
Crizotinib |
Anti-Oncology |
CAS NO: 877399-52-5
Molecular formula: C21H22Cl2FN5O
Molecular weight: 450.343
Standard: USP/BP/EP/CP
Application: A potential antitumor agent |
Appearance:white to off-white crystalline Powder
Identification:IR,H-NMR Loss on Drying:≤0.2% Residue on ignition: ≤0.1% Assay(HPLC):98.5%~101.5%(Calculated on anhydrous substance) |
| 444731-52-6 |
Pazopanib |
Anti-Oncology |
CAS NO: 444731-52-6
Molecular formula: C21H23N7O2S
Molecular weight: 437.52
Standard: USP/BP/EP/CP
Application: Used as its hydrochloride salt for treatment of kidney cancer |
Appearance: off-white powder
Identification:IR,H-NMR Residue on ignition： ≤0.2% Heavy metals(Pb)：≤20ppm Moisture：≤0.05% Purity：≥99% |
| 868540-17-4 |
Carfilzomib |
Anti-Oncology |
CAS NO: 868540-17-4
Molecular formula: C40H57N5O7
Molecular weight: 719.91 Standard: USP/BP/EP/CP
Application: Used as a treatment in relapsed and refractory multiple myeloma |
Appearance:White or almost white powder
Identification:IR,H-NMR PH ;9.2~10.2 Loss on drying:≤ 1.0 % Sulphated ash:≤ 0.2 % Assay:98.5% ~ 101.0%(dried substance) |
| 380843-75-4 |
Bosutinib |
Anti-Oncology |
CAS NO: 380843-75-4
Molecular formula: C26H29Cl2N5O3
Molecular weight: 530.45 Standard: USP/BP/EP/CP
Application: A novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells |
Appearance:white to off-white crystalline Powder
Identification:IR,H-NMR Heavy metals:≤10 ppm Water:≤1.0% Sulphated ash:≤0.5% Assay:99.0%~101.0% (anhydrous substance) |
| 656247-17-5 |
Intedanib |
Anti-Oncology |
CAS NO: 656247-17-5 Molecular formula: C31H33N5O4
Molecular weight: 539.62482 Standard: USP/BP/EP/CP
Application: Used for the treatment of idiopathic pulmonary fibrosis and cancer |
Appearance:white to off-white crystalline Powder
Identification:IR,H-NMR Moisture:≤1.5% Assay(By HPLC) :≥99.0% |
| 57852-57-0
|
Idarubicin hydrochloride |
Anti-Oncology |
CAS NO: 57852-57-0
Molecular formula: C26H27NO9.HCl
Molecular weight: 533.95
Standard: USP/BP/EP/CP Application:Orally active anthracycline; analog of Daunorubicin. Antineoplastic |
Appearance:white to off-white crystalline Powder
Identification:IR,H-NMR Water:≤0.5% Residue on Ignition:≤0.2% Assay:99.0~101.0% (calculated on anhydrous
and solvent free basis) |
| 668270-12-0 |
Linagliptin |
Anti-diabetic |
CAS NO: 668270-12-0
Molecular formula: C25H28N8O2
Molecular weight: 472.54
Standard: USP/BP/EP/CP
Application: Antidiabetic |
Appearance: off-white to light-yellow crystalline powder
Identification:IR,H-NMR Loss on drying：≤1.0% Residue on Ignition：≤0.1% Heavy Metals：≤20ppm Purity：≥99.0% |
| 850649-62-6 |
Alogliptin benzoate |
Anti-diabetic |
CAS NO: 850649-62-6
Molecular formula: C18H21N5O2.C7H6O2
Molecular weight: 461.52
Standard: USP/BP/EP/CP
Application: Antidiabetic |
Appearance:white to off-white crystalline Powder
Identification:IR,H-NMR Melting Range：181~185°C Loss on drying：≤0.5% Residue on Ignition：≤0.1% Heavy metals：≤0.002% Assay(On dried basis)：99.0% |
| 709031-78-7 |
Saxagliptin hydrochloride |
Anti-diabetic |
CAS NO: 709031-78-7
Molecular formula: C18H25N3O2.HCl
Molecular weight: 351.87
Standard: USP/BP/EP/CP
Application: Antidiabetic |
Appearance:White or off-white powder
IdentificationH-NMR
Assay:98.0%~101.0%(Calculated on anhydrous substance) |
| 461432-26-8 |
Dapagliflozin |
Anti-diabetic |
CAS NO: 461432-26-8
Molecular formula: C21H25ClO6
Molecular weight: 408.87
Standard: Enterprise standard
Application: Antidiabetic |
Description:White to off-white crystalline powder
Identification:H-NMR/LC-MS
Loss on drying:≤1.0%
Water:≤1.0%
Residue on ignition:≤0.5%
Purity(HPLC):≥98.0% |
| 928672-86-0 |
Canagliflozin hemihydrate |
Anti-diabetic |
CAS NO: 928672-86-0
Molecular formula: 2(C24H25FO5S).H2O
Molecular weight: 907.05 |
Appearance:White to off white crystalline powder
Identification:IR,H-NMR Melting point：166-170°C Related substances：≤1.0% Loss on drying;≤0.5% Residue on ignition:≤0.1% Heavy Metals:≤20ppm Purity(HPLC):≥98.0% |
| 864070-44-0 |
Empagliflozin |
Anti-diabetic |
CAS NO: 864070-44-0
Molecular formula: C23H27ClO7
Molecular weight: 450.91 |
Appearance:White to off white crystalline powder
Identification:IR,H-NMR Related substances：≤1.0% Loss on drying;≤0.5% Residue on ignition:≤0.1% Heavy Metals:≤20ppm Purity(HPLC):≥98.0% |
| 503612-47-3 |
Apixaban |
Anti-coagulant |
CAS NO: 503612-47-3
Molecular formula: C25H25N5O4
Molecular weight: 459.50
Standard: Enterprise standard
Application: Anticoagulant |
Appearance:White to off-white powder
Identification:H-NMR/HPLC
Melting point:175.0-178.0℃
Loss on drying:≤1.0% Heavy metal:≤20ppm
Assay:98.0%~102.0%(calculated on anhydrous substance) |
| 679809-58-6
|
Enoxaparin Sodium |
Anti-coagulant |
CAS NO: 679809-58-6
Standard: BP/USP/EP/CP Molecular formula: C12H16NS2Na3)20
Molecular weight: 288.42800
Standard: BP/USP/EP/CP
Application: Anti-coagulant |
Appearance:hite to off-white powder
Identification:IR,H-NMR Grade: Crude and Fine |
| 151319-34-5 |
Zaleplon |
Sedative-hypnotic |
CAS NO: 151319-34-5
Molecular formula: C17H15N5O
Molecular weight: 305.34
Appearance: white or almost white powder
Standard: BP/USP/EP/CP
Application: Sedative-hypnotics |
This product needs buyer supply permit from local MOH. |
| 89365-50-4 |
Salmeterol |
Bronchodilator |
CAS NO: 89365-50-4 Molecular formula: C25H37NO4
Molecular weight: 415.57
Standard: BP/USP/EP/CP
Application: Sedative-hypnotics |
Appearance:White to off-white powder
Identification:IR,H-NMR Specific rotation:+39.5 to +41.5° Loss on drying:≤0.2% Residue on ignition:≤0.1% Assay:≥99% |
| 160970-54-7 |
Silodosin |
Urinary
|
CAS NO: 160970-54-7
Molecular formula: C25H32F3N3O4
Molecular weight: 495.53
Standard: Enterprise standard
Application: Urinary |
Appearance:White or almost white crystalline powder
Identification:HPLC/IR
Loss on drying:≤0.1%
EE:≥99.0%
Residue on ignition:≤0.1%
Heavy metals:≤20ppm
Assay:99.0%~100.0%(Calculated on anhydrous substance) |
| 111911-87-6 |
Rebamipide |
Gastric mucosa protective |
CAS NO: 90098-04-7/111911-87-6
Molecular formula: C19H15ClN2O4
Molecular weight: 370.072
Standard: Enterprise standard
Application: Gastric mucosa protectives |
Appearance:White or off-white crystalline powder
Solubility:Soluble in N,N-Dimethylformamide,(DMF), Sparingly soluble in Methanol, insoluble in water
Identification:IR/HPLC
Loss on drying:≤2.0%
Residue on ignition:≤0.1%
Heavy metals:≤10ppm
Assay:≥99.0%(Calculated on anhydrous substance) |
| 668270-12-0 |
Linagliptin |
Anti-diabetic |
CAS NO: 668270-12-0
Molecular formula: C25H28N8O2
Molecular weight: 472.54
Standard: USP/BP/EP/CP
Application: A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
Appearance:White or off-white crystalline
powder
Identification:IR,H-NMR Loss on drying:≤1.0% Residue on Ignition:≤0.1% Heavy Metals：≤20ppm Purity;≥99.0%(Calculated on anhydrous substance) |
| 274901-16-5 |
Vildagliptin |
Anti-diabetic |
CAS NO: 274901-16-5
Molecular formula: C17H25N3O2
Molecular weight: 303.39900
Standard: USP/BP/EP/CP
Application: It is a new oral anti-hyperglycemic agent of a new dipeptidyl peptidase-IV (DPP-IV) inhibitor class of drugs. |
Appearance:White crystalline powder
Identification:IR,H-NMR Melting point:148.0-150.0°C Loss on drying: ≤ 1.0% Residue on ignition:≤ 0.1% Heavy metals:≤20ppm Assay:≥99.0%(Calculated on anhydrous substance) |
| 480449-70-5 |
Edoxaban |
Anti-thrombus |
CAS NO: 480449-70-5
Molecular formula: C24H30ClN7O4S
Molecular weight: 548.065
Standard: USP/BP/EP/CP
Application: A monocarboxylic acid amide that is used (as its tosylate monohydrate) for the treatment of deep vein thrombosis and pulmonary embolism |
Appearance:White or off-white crystalline
powder
Identification:IR,H-NMR Loss on drying:≤2.5% Residue on Ignition:≤0.1% Heavy Metals：≤20ppm Purity;≥98.5%(Calculated on anhydrous substance) |
| 496775-61-2 |
Eltrombopag |
Thrombocytopenia |
CAS NO: 496775-61-2
Molecular formula: C25H22N4O4
Molecular weight: 442.47
Standard: USP/BP/EP/CP
Application: An agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia |
Appearance:White or off-white crystalline
powder
Identification:IR,H-NMR Loss on drying:≤5.0% Ash:≤5.0% Lead(Pb)：≤3.0mg/kg Total Plate Count:≤1000cfu/g Purity;≥98.5%(Calculated on anhydrous substance) |
| 461432-26-8 |
Dapagliflozin |
Anti-diabetic |
CAS NO: 461432-26-8
Molecular formula: C21H25ClO6
Molecular weight: 408.8726
Standard: USP/BP/EP/CP
Application: therapeutic for diabetes I or II, and hyperglycemia |
Appearance:White or off-white crystalline
powder
Identification:IR,H-NMR Boiling Point：609ºC at 760mmHg Purity;≥98.5%(Calculated on anhydrous substance) |
| 477600-75-2 |
Tofacitinib |
Rheumatoid arthritis |
CAS NO: 477600-75-2
Molecular formula: C16H20N6O
Molecular weight: 312.3696
Standard: USP/BP/EP/CP
Application: As Janus kinase inhibitor for treatment of rheumatoid arthritis |
Appearance:White or off-white crystalline
powder
Identification:IR,H-NMR Loss on drying：≤0.2% Water content(KF)：≤0.5% Purity(by HPLC)：≥98.5% |
| 402957-28-2 |
Telaprevir |
Peptidomimetic inhibitor |
CAS NO: 402957-28-2
Molecular formula: C36H53N7O6
Molecular weight: 679.85
Standard: USP/BP/EP/CP
Application: A peptidomimetic inhibitor of hepatitis C virus protease |
Appearance:White or off-white crystalline
powder
Identification:IR,H-NMR Loss on drying：≤0.2% Residue on ignition:≤0.1% Heavy Metals: ≤10PPM Purity(by HPLC)：≥98.5% |
| 330784-47-9 |
Avanafil |
PDE5 inhibitor |
CAS NO: 330784-47-9
Molecular formula: C23H26ClN7O3
Molecular weight: 483.95
Standard: USP/BP/EP/CP
Application: Used for treatment of erectile dysfunction. |
Appearance:White or off-white crystalline power
Identification:IR,H-NMR Melting point：162-165°C Heavy metals：≤10ppm Loss on drying：≤0.5% Sulphated ash：≤0.1% Purity(HPLC)：≥98% |
